Rashin zuciya - magunguna

Yawancin mutanen da ke da raunin zuciya suna buƙatar shan magunguna. Ana amfani da wasu daga waɗannan magungunan don magance alamunku. Wasu kuma na iya taimakawa hana karyewar zuciyar ka daga zama mai muni kuma su baka tsawon rai.

Kuna buƙatar shan yawancin magungunan zuciya na zuciya kowace rana. Ana shan wasu magunguna sau ɗaya a rana. Wasu na bukatar a sha sau 2 ko sama da haka a kowace rana. Yana da matukar mahimmanci ka sha magungunan ka a lokacin da ya dace da kuma yadda likitanka ya fada maka.

Kada ka daina shan magungunan zuciyarka ba tare da yin magana da mai ba da lafiyar ka ba tukuna. Hakanan haka yake ga sauran magunguna da kuke sha, kamar magunguna don ciwon suga, hawan jini, da sauran mawuyacin yanayi.

Mai ba da sabis ɗinku na iya gaya muku ku sha wasu magunguna ko ku canza allurai lokacin da alamunku suka yi tsanani. KADA KA canza magunguna ko allurai ba tare da yin magana da mai bayarwa ba.

Koyaushe gaya wa mai ba ku sabis kafin ku ɗauki sababbin magunguna. Wannan ya hada da magunguna irin su ibuprofen (Advil, Motrin) da naproxen (Aleve, Naprosyn), da kuma kwayoyi irin su sildenafil (Viagra), vardenafil (Levitra), da tadalafil (Cialis).

Har ila yau, gaya wa mai ba ka sabis kafin ka ɗauki kowane irin ganye ko kari.

ACE masu hanawa (angiotensin masu canza masu enzyme) da kuma ARBs (masu hana masu karɓar maganin angiotensin II) suna aiki ta buɗe hanyoyin jini da rage hawan jini. Wadannan magunguna na iya:

• Rage aikin da zuciyar ka zata yi
• Taimakawa tsokar zuciyar ka ta kara kyau
• Ka kiyaye gazawar zuciyar ka daga yin muni

Illolin gama gari na waɗannan ƙwayoyin sun haɗa da:

• Dry tari
• Haskewar kai
• Gajiya
• Ciwan ciki
• Edema
• Ciwon kai
• Gudawa

Lokacin da kuka sha waɗannan magungunan, kuna buƙatar yin gwajin jini don bincika yadda kododarku ke aiki da kuma auna matakan potassium ɗin ku.

Yawancin lokaci, mai ba da sabis ɗinku zai tsara ko dai mai hana ACE ko ARB. Wani sabon rukunin magani da ake kira angiotensin receptor-neprilysin inhibitors (ARNI’s) ya hada maganin ARB da wani sabon nau'in magani. Ana iya amfani da ARNI's don magance ciwon zuciya.

Masu toshe Beta suna rage bugun zuciyar ku kuma rage ƙarfin da jijiyar zuciyar ku ke aiki da shi a cikin gajeren lokaci. Dogon beta masu toshewa suna taimakawa kiyaye bugun zuciyar ku daga zama mafi muni. Bayan lokaci kuma suna iya taimakawa ƙarfafa zuciyar ka.

Masu hana beta na yau da kullun da ake amfani da su don gazawar zuciya sun haɗa da carvedilol (Coreg), bisoprolol (Zebeta), da metoprolol (Toprol).

KADA KA hanzarta ka daina shan waɗannan magungunan. Wannan na iya kara haɗarin angina har ma da bugun zuciya. Sauran illolin sun hada da saukin kai, bacin rai, kasala, da karfin tunani.

Diuretics suna taimakawa jikinka ya rabu da ƙarin ruwa. Wasu nau'ikan diuretics na iya taimakawa ta wasu hanyoyi. Wadannan kwayoyi ana kiran su sau da yawa "kwayoyin kwayoyi." Akwai nau'ikan alamun diuretics. Ana shan wasu sau ɗaya a rana. Wasu kuma ana shan su sau 2 a rana. Mafi yawan nau'ikan sune:

• Thiazides. Chlorothiazide (Diuril), chlorthalidone (Hygroton), indapamide (Lozol), hydrochlorothiazide (Esidrix, HydroDiuril), da metolazone (Mykrox, Zaroxolyn)
• Madauki madaukai Bumetanide (Bumex), furosemide (Lasix), da torasemide (Demadex)
• Magunguna masu kare sinadarin potassium. Amiloride (Midamor), spironolactone (Aldactone), da triamterene (Dyrenium)

Lokacin da kuka sha waɗannan magunguna, kuna buƙatar gwajin jini akai-akai don bincika yadda kododarku ke aiki da kyau kuma ku auna matakan potassium.

Mutane da yawa da ke fama da cututtukan zuciya suna shan asfirin ko clopidogrel (Plavix). Wadannan kwayoyi suna taimakawa hana yaduwar jini daga samuwar jijiyoyin ku. Wannan na iya rage haɗarin bugun jini ko bugun zuciya.

An bada shawarar Coumadin (Warfarin) ga marasa lafiya da ke fama da ciwon zuciya waɗanda ke da haɗari mafi girma na daskarewar jini.Kuna buƙatar yin ƙarin gwaje-gwajen jini don tabbatar da cewa adadin ku daidai ne. Hakanan zaka iya buƙatar yin canje-canje ga abincinka.

Magungunan da ba a amfani da su sosai don gazawar zuciya sun haɗa da:

• Digoxin don taimakawa haɓaka ƙarfin bugun zuciya da rage saurin bugun zuciya.
• Hydralazine da nitrates don buɗe jijiyoyi da kuma taimakawa tsokar zuciya ta fi kyau. Ana amfani da waɗannan magungunan galibi ne ga marasa lafiya waɗanda ba za su iya jure wa masu hana ACE da masu toshe mai karɓar angiotensin ba.
• Masu toshe tashar Calcium don sarrafa hawan jini ko angina (ciwon kirji) daga cututtukan jijiyoyin jini (CAD).

Ana amfani da Statins da sauran magungunan rage cholesterol lokacin da ake buƙata.

Wasu lokuta ana amfani da magungunan antiarrhythmic ta marasa lafiya masu fama da ciwon zuciya waɗanda ke da larurar bugun zuciya. Suchaya daga cikin irin waɗannan magungunan shine amiodarone.

Wani sabon magani, Ivabradine (Corlanor), yana aiki don rage bugun zuciya kuma yana iya taimaka wa mutane masu fama da ciwon zuciya ta hanyar rage aikin zuciya.

CHF - magunguna; Ciwon zuciya mai narkewa - magunguna; Cardiomyopathy - magunguna; HF - magunguna

Mann DL. Gudanar da marasa lafiya tare da raunin zuciya tare da rage ɓangaren fitarwa. A cikin: Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E, eds. Braunwald na Ciwon Zuciya: Littafin rubutu na Magungunan zuciya da jijiyoyin jini. 11th ed. Philadelphia, PA: Elsevier Saunders; 2019: sura 25.

Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC / AHA / HFSA ta ƙaddamar da sabuntawa na jagorancin 2013 ACCF / AHA don kula da rashin nasarar zuciya: rahoto na Kwalejin Kwalejin Zuciya ta Amurka / Heartungiyar Associationungiyar Heartungiyar Zuciya ta Amurka game da Sharuɗɗan Ayyukan Clinical da Faungiyar Rashin Ciwon Zuciya ta Amurka. J Rashin Karfin zuciya. 2017; 23 (8): 628-651. PMID: 28461259 www.ncbi.nlm.nih.gov/pubmed/28461259.

Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF / AHA jagora don gudanar da rashin cin nasara zuciya: rahoto na Kwalejin Kwalejin Kwakwar Kwakiyar Amurka / Heartungiyar Heartungiyar Heartungiyar Zuciya ta Amurka kan Ka'idodin Aiki. Kewaya. 2013; 128 (16): e240-e327. PMID: 23741058 www.ncbi.nlm.nih.gov/pubmed/23741058.

• Rushewar Zuciya